CATHERINE RIVERA: Open Payments
NPI 1376177550 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$404 in 16 payments from 11 companies in 2025. Trend: 2023 $389 · 2024 $306 · 2025 $404
Food & beverage: $404
| Company | Payments | Amount |
|---|---|---|
| Janssen Scientific Affairs, LLC | 2 | $77 |
| Daiichi Sankyo Inc. | 2 | $59 |
| AstraZeneca Pharmaceuticals LP | 2 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| Sumitomo Pharma America, Inc. | 2 | $41 |
| Janssen Biotech, Inc. | 1 | $26 |
| Caris MPI, Inc. | 1 | $25 |
| Blue Earth Diagnostics | 1 | $24 |
| Lilly USA, LLC | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $21 |
Products named: ERLEADA, Enhertu, PLUVICTO, GEMTESA, DATROWAY, DARZALEX, MI CANCER SEEK, POSLUMA.
Industry payments across FL — which companies pay providers there.
